Works matching IS 09395555 AND DT 2023 AND VI 102 AND IP 2
Results: 35
Correction to: A real‑world experience of eltrombopag plus rabbit antithymocyte immunoglobulin–based IST in Chinese patients with severe aplastic anemia.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 385, doi. 10.1007/s00277-023-05100-0
- By:
- Publication type:
- Article
Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 271, doi. 10.1007/s00277-023-05099-4
- By:
- Publication type:
- Article
Prognostic significance of absolute monocyte count and lymphocyte to monocyte ratio in mucosa-associated lymphoid tissue (MALT) lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 359, doi. 10.1007/s00277-023-05098-5
- By:
- Publication type:
- Article
Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 329, doi. 10.1007/s00277-023-05096-7
- By:
- Publication type:
- Article
Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 249, doi. 10.1007/s00277-023-05095-8
- By:
- Publication type:
- Article
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 393, doi. 10.1007/s00277-023-05092-x
- By:
- Publication type:
- Article
Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 421, doi. 10.1007/s00277-023-05091-y
- By:
- Publication type:
- Article
Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 499, doi. 10.1007/s00277-022-05082-5
- By:
- Publication type:
- Article
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 349, doi. 10.1007/s00277-022-05080-7
- By:
- Publication type:
- Article
Early cerebrospinal fluid infiltration in TP53-mutated blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 491, doi. 10.1007/s00277-022-05078-1
- By:
- Publication type:
- Article
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 323, doi. 10.1007/s00277-022-05075-4
- By:
- Publication type:
- Article
The KMT2A rearrangement is an early event prior to KMT2A-PTD in AML patients with both molecular aberrations.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 495, doi. 10.1007/s00277-022-05074-5
- By:
- Publication type:
- Article
Comparative efficacy and safety of restrictive versus liberal transfusion thresholds in anemic preterm infants: a meta-analysis of 12 randomized controlled trials.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 283, doi. 10.1007/s00277-022-05072-7
- By:
- Publication type:
- Article
Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 311, doi. 10.1007/s00277-022-05071-8
- By:
- Publication type:
- Article
The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 439, doi. 10.1007/s00277-022-05064-7
- By:
- Publication type:
- Article
Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 463, doi. 10.1007/s00277-022-05063-8
- By:
- Publication type:
- Article
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 413, doi. 10.1007/s00277-022-05062-9
- By:
- Publication type:
- Article
Real-world experience and considerations on concomitant caplacizumab and anticoagulation in thrombotic thrombocytopenic purpura.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 457, doi. 10.1007/s00277-022-05049-6
- By:
- Publication type:
- Article
Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 487, doi. 10.1007/s00277-022-05048-7
- By:
- Publication type:
- Article
EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 471, doi. 10.1007/s00277-022-05060-x
- By:
- Publication type:
- Article
Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal nocturnal hemoglobinuria.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 299, doi. 10.1007/s00277-022-05055-8
- By:
- Publication type:
- Article
Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 483, doi. 10.1007/s00277-022-05053-w
- By:
- Publication type:
- Article
Inherited transmission of the CSF3R T618I mutation: a familial report.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 477, doi. 10.1007/s00277-022-05050-z
- By:
- Publication type:
- Article
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 261, doi. 10.1007/s00277-022-05057-6
- By:
- Publication type:
- Article
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 369, doi. 10.1007/s00277-022-05056-7
- By:
- Publication type:
- Article
Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 473, doi. 10.1007/s00277-022-05047-8
- By:
- Publication type:
- Article
Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent β-thalassemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 467, doi. 10.1007/s00277-022-05046-9
- By:
- Publication type:
- Article
Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 461, doi. 10.1007/s00277-022-05045-w
- By:
- Publication type:
- Article
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 429, doi. 10.1007/s00277-022-05011-6
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation in patients with a prior history of prostate cancer.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 407, doi. 10.1007/s00277-022-05041-0
- By:
- Publication type:
- Article
Neurolymphomatosis of cranial nerves as the responsible lesions for the vocal cord paralysis and facial nerve palsy in a patient with diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 481, doi. 10.1007/s00277-022-05038-9
- By:
- Publication type:
- Article
Measurable residual disease detected by flow cytometry independently predicts prognoses of NPM1-mutated acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 337, doi. 10.1007/s00277-022-05033-0
- By:
- Publication type:
- Article
BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 403, doi. 10.1007/s00277-022-05026-z
- By:
- Publication type:
- Article
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 447, doi. 10.1007/s00277-022-05044-x
- By:
- Publication type:
- Article